[Federal Register: October 3, 2005 (Volume 70, Number 190)]
[Notices]
[Page 57602-57607]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03oc05-114]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
Privacy Act of 1974; Report of a New System of Records
AGENCY: Department of Health and Human Services (HHS), Center for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a New System of Records (SOR).
-----------------------------------------------------------------------
SUMMARY: In accordance with the requirements of the Privacy Act of
1974, we are proposing to create a new system titled, ``Cancer
Prevention and Treatment Demonstration for Ethnic and Racial Minorities
(CPTD) System, System No. 09-70-0560.'' Section 122 of the Medicare,
Medicaid, and State Children's Health Insurance Program (SCHIP)
Benefits Improvement and Protection Act of 2000 (BIPA) (Public Law
(Pub. L.) 106-554) grants CMS the authority to award at least nine
cooperative agreement demonstration projects that will identify methods
to reduce disparities in early cancer screening, diagnosis, and
treatment for Black, Hispanic, Asian American and Pacific Islander, and
American Indian (including Alaskan Native, Eskimo, and Aleut) Medicare
beneficiary populations. Demonstration sites will use the best
available scientific evidence to identify promising models of cancer
screening, diagnosis and treatment interventions to promote health and
appropriate utilization of Medicare covered services, eliminate
disparities in cancer detection and treatment among ethnic and racial
populations of Medicare beneficiaries, and provide information to
improve the effectiveness of the Medicare program.
The purpose of this system is to collect and maintain demographic
and cancer health-related data on Medicare target population
beneficiaries who voluntarily enroll in the CPTD Project for Ethnic and
Racial Minorities. This system will enable CMS to enroll eligible
participants in the demonstration project; randomize participants into
intervention and control groups; reimburse demonstration site service
claims; and develop, maintain and analyze/evaluate research information
showing the potential impact of providing cancer screening, diagnosis
and treatment facilitation services to underserved Medicare
beneficiaries. Information retrieved from this system may be disclosed
to: (1) Support regulatory, reimbursement, and policy functions
performed within the agency or by a contractor, grantee, consultant or
other legal agent; (2) assist another Federal or state agency with
information to enable such agency to administer a Federal health
benefits program, or to enable such agency to fulfill a requirement of
Federal statute or regulation that implements a health benefits program
funded in whole or in part with Federal funds; (3) assist an individual
or organization engaged in the performance activities of the
demonstration or in a research project or in support of an evaluation
project related to the prevention of disease or disability, the
restoration or maintenance of health, or payment related projects; (4)
support constituent requests made to a congressional representative;
(5) support litigation involving the agency; and (6) combat fraud and
abuse in certain health benefits programs. We have provided background
information about the new system in the Supplementary
[[Page 57603]]
Information section below. Although the Privacy Act requires only that
CMS provide an opportunity for interested persons to comment on the
proposed routine uses, CMS invites comments on all portions of this
notice. See Dates section for comment period.
DATES: CMS filed a new SOR report with the Chair of the House Committee
on Government Reform and Oversight, the Chair of the Senate Committee
on Governmental Affairs, and the Administrator, Office of Information
and Regulatory Affairs, Office of Management and Budget (OMB) on
September 26, 2005. In any event, we will not disclose any information
under a routine use until 40 days after publication. We may defer
implementation of this system or one or more of the routine use
statements listed below if we receive comments that persuade us to
defer implementation.
ADDRESSES: The public should address comment to the CMS Privacy
Officer, Mail-stop N2-04-27, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850. Comments received will be available for review at
this location by appointment during regular business hours, Monday
through Friday from 9 a.m.-3 p.m., eastern time.
FOR FURTHER INFORMATION CONTACT: C. Diane Merriman, Project Officer,
Division of Health Promotion and Disease Prevention Demonstrations,
Office of Research Development and Information, CMS, Mail Stop S3-07-
04, 7500 Security Boulevard, Baltimore, Maryland 21244-1849, telephone
number (410) 786-7237, e-mail Diane.Merriman@cms.hhs.gov.
SUPPLEMENTARY INFORMATION: Section 122 of the Medicare, Medicaid, and
SCHIP Benefits Improvement and Protection Act of 2000 (BIPA) (Pub. L.
106-554) requires CMS to design and implement at least nine
demonstration projects in specific target populations for the purpose
of developing models and evaluating methods that: (1) Improve the
quality of items and services provided to target individuals in order
to facilitate reduced disparities in early detection and treatment of
cancer; (2) improve clinical outcomes, satisfaction, quality of life,
and appropriate use of Medicare-covered services and referral patterns
among those target individuals with cancer; (3) eliminate disparities
in the rate of preventive cancer screening measures; and (4) promote
collaboration with community-based organizations to ensure cultural
competency of health care professionals and linguistic access for
persons with limited English proficiency. Each of the following four
legislatively-mandated target populations are required to be the
subject of two separate demonstration projects: American Indians
(including Alaskan Natives, Eskimos and Aleuts); Asian Americans and
Pacific Islanders; Blacks; and Hispanics. If the initial demonstration
evaluation indicates that these projects (1) reduce Medicare
expenditures; or (2) do not increase Medicare expenditures, reduce
ethnic and racial health disparities, and increase beneficiary and
health care provider satisfaction, the existing demonstration projects
will continue, and the number of demonstration projects may be expanded
in the future.
I. Description of the Proposed System of Records
A. Statutory and Regulatory Basis for SOR
The statutory authority for this system is given under the
provisions of Section 122 of the Medicare, Medicaid, and State
Children's Health Insurance Program (SCHIP) Benefits Improvement and
Protection Act of 2000 (BIPA) (Pub. L. 106-554).
B. Collection and Maintenance of Data in the System
This system will collect and maintain individually identifiable
demographic and cancer health-related data collected on Medicare target
population beneficiaries who voluntarily enroll in the CPTD for Ethnic
and Racial Minorities. The system will maintain information on two
populations: (1) Medicare beneficiaries belonging to a defined ethnic
or racial minority group who do not have a current diagnosis of cancer
before enrollment in the demonstration project; and (2) Medicare
beneficiaries belonging to a defined ethnic or racial minority who have
been diagnosed with cancer before enrollment in the demonstration
project. The collected information will contain name, address,
telephone number, Medicare health insurance claim (HIC) number, race/
ethnicity, gender type, and date of birth, as well as background
information relating to Medicare issues. It will also include cancer
screening, diagnosis, treatment, project enrollment and evaluation,
survey and research information needed to administer the demonstration
project and develop research reports on the demonstration findings.
II. Agency Policies, Procedures, and Restrictions on the Routine Use
A. The Privacy Act permits us to disclose information without an
individual's consent if the information is to be used for a purpose
that is compatible with the purpose(s) for which the information was
collected. Any such disclosure of data is known as a ``routine use.''
The Government will only release CPTD information that can be
associated with an individual as provided for under ``Section III.
Proposed Routine Use Disclosures of Data in the System.'' Both
identifiable and non-identifiable data may be disclosed under a routine
use. We will only collect the minimum personal data necessary to
achieve the purpose of CPTD.
CMS has the following policies and procedures concerning
disclosures of information that will be maintained in the system.
Disclosure of information from the system will be approved only to the
extent necessary to accomplish the purpose of the disclosure and only
after CMS:
1. Determines that the use or disclosure is consistent with the
reason that the data is being collected; e.g., to collect and maintain
demographic and cancer health-related data on Medicare target
population beneficiaries who voluntarily enroll in the CPTD Project for
Ethnic and Racial Minorities.
2. Determines that:
a. The purpose for which the disclosure is to be made can only be
accomplished if the record is provided in individually identifiable
form;
b. The purpose for which the disclosure is to be made is of
sufficient importance to warrant the effect and/or risk on the privacy
of the individual that additional exposure of the record might bring;
and
c. There is a strong probability that the proposed use of the data
would in fact accomplish the stated purpose(s).
3. Requires the information recipient to:
a. Establish administrative, technical, and physical safeguards to
prevent unauthorized use or disclosure of the record;
b. Remove or destroy, at the earliest time, all patient-
identifiable information; and
c. Agree to not use or disclose the information for any purpose
other than the stated purpose under which the information was
disclosed.
4. Determines that the data are valid and reliable.
III. Proposed Routine Use Disclosures of Data in the System
A. The Privacy Act allows us to disclose information without an
individual's consent if the information is to be used for a purpose
that is compatible with the purpose(s) for which the information was
collected.
[[Page 57604]]
Any such compatible use of data is known as a ``routine use.'' The
proposed routine uses in this system meet the compatibility requirement
of the Privacy Act. We are proposing to establish the following routine
use disclosures of information maintained in the system:
1. To agency contractors, grantees, consultants or other legal
agents who have been engaged by the agency to assist in the performance
of a service related to this system of records and who need to have
access to the records in order to perform the activity.
We contemplate disclosing information under this routine use only
in situations in which CMS may enter into a contractual, grantee,
cooperative agreement or consultant relationship with a third party to
assist in accomplishing CMS functions relating to purposes for this
system or records. CMS occasionally contracts out certain of its
functions when doing so would contribute to effective and efficient
operations. CMS must be able to give a contractor, grantee, consultant
or other legal agent whatever information is necessary for the agent to
fulfill its duties. In these situations, safeguards are provided in the
contract prohibiting the agent from using or disclosing the information
for any purpose other than that described in the contract and requires
the agent to return or destroy all information at the completion of the
contract.
2. To another Federal or state agency to:
a. Contribute to the accuracy of CMS's proper payment of Medicare
benefits;
b. Enable such agency to administer a Federal health benefits
program, or, as necessary, to enable such agency to fulfill a
requirement of a Federal statute or regulation that implements a health
benefits program funded in whole or in part with Federal funds; and/or
c. Assist Federal/state Medicaid programs within the state.
Other Federal or state agencies, in their administration of a
Federal health program, may require CPTD information in order to
support evaluations and monitoring of Medicare claims information of
beneficiaries, including proper reimbursement for services provided.
3. To an individual or organization engaged in or assisting in the
enrollment, screening, diagnosis, treatment, evaluation, or research
efforts relative to beneficiary participation in the CPTD for Ethnic
and Racial Minorities (including summary analyses demonstrating the
impact of the demonstration project), and other activities reasonably
necessary to fulfill the provisions of the demonstration project and
ensure appropriate use of Medicare trust funds and program funds, as
well as to an individual or organization for a research project or in
support of an evaluation project related to the prevention of disease
or disability, the restoration or maintenance of health, the reduction
of healthcare disparities, or payment related projects.
The CPTD data will provide for research or support of evaluation
projects and a broader, longitudinal, national perspective of the
status of Medicare beneficiaries. CMS anticipates that many researchers
will have legitimate requests to use these data in projects that could
ultimately improve the care provided to Medicare beneficiaries and the
policies that govern their care.
4. To a Member of Congress or to a congressional staff member in
response to an inquiry of the congressional office made at the written
request of the constituent about whom the record is maintained.
Beneficiaries sometimes request the help of a Member of Congress in
resolving an issue relating to a matter before CMS. The Member of
Congress then writes to CMS, and CMS must be able to give sufficient
information to be responsive to the inquiry.
5. To the Department of Justice (DOJ), court or adjudicatory body
when:
a. The agency or any component thereof, or
b. Any employee of the agency in his or her official capacity, or
c. Any employee of the agency in his or her individual capacity
where the DOJ has agreed to represent the employee, or
d. The United States Government, is a party to litigation or has an
interest in such litigation, and, by careful review, CMS determines
that the records are both relevant and necessary to the litigation and
that the use of such records by the DOJ, court or adjudicatory body is
compatible with the purpose for which the agency collected the records.
Whenever CMS is involved in litigation, and occasionally when
another party is involved in litigation and CMS policies or operations
could be affected by the outcome of the litigation, CMS would be able
to disclose information to the DOJ, court or adjudicatory body
involved.
6. To a CMS contractor (including, but not necessarily limited to,
fiscal intermediaries and carriers) that assists in the administration
of a CMS-administered health benefits program, or to a grantee of a
CMS-administered grant program, when disclosure is deemed reasonably
necessary by CMS to prevent, deter, discover, detect, investigate,
examine, prosecute, sue with respect to, defend against, correct,
remedy, or otherwise combat fraud or abuse in such program.
We contemplate disclosing information under this routine use only
in situations in which CMS may enter into a contractual, grantee,
cooperative agreement or consultant relationship with a third party to
assist in accomplishing CMS functions relating to the purpose of
combating fraud and abuse. CMS occasionally contracts out certain of
its functions or makes grants or cooperative agreements when doing so
would contribute to effective and efficient operations. CMS must be
able to give a contractor, grantee, consultant or other legal agent
whatever information is necessary for the agent to fulfill its duties.
In these situations, safeguards are provided in the contract
prohibiting the agent from using or disclosing the information for any
purpose other than that described in the contract and requiring the
agent to return or destroy all information.
7. To another Federal agency or to an instrumentality of any
governmental jurisdiction within or under the control of the United
States (including any State or local governmental agency), that
administers, or that has the authority to investigate potential fraud
or abuse in, a health benefits program funded in whole or in part by
Federal funds, when disclosure is deemed reasonably necessary by CMS to
prevent, deter, discover, detect, investigate, examine, prosecute, sue
with respect to, defend against, correct, remedy, or otherwise combat
fraud or abuse in such programs.
Other agencies may require CPTD information for the purpose of
combating fraud and abuse in such Federally-funded programs.
B. Additional Provisions Affecting Routine Use Disclosures
This system contains Protected Health Information (PHI) as defined
by HHS regulation ``Standards for Privacy of Individually Identifiable
Health Information'' (45 CFR Parts 160 and 164, 65 FR 82462 (12-28-00),
Subparts A and E). Disclosures of PHI authorized by these routine uses
may only be made if and as permitted or required by the ``Standards for
Privacy of Individually Identifiable Health Information.''
In addition, our policy will be to prohibit release even of not
directly identifiable information, except pursuant to one of the
routine uses or if required by law, if we determine there is a
possibility that an individual can be identified through implicit
deduction
[[Page 57605]]
based on small cell sizes (instances where the patient population is so
small that individuals who are familiar with the enrollees could,
because of the small size, use this information to deduce the identity
of the beneficiary).
IV. Safeguards
CMS has safeguards in place for authorized users and monitors such
users to ensure against excessive or unauthorized use. Personnel having
access to the system have been trained in the Privacy Act and
information security requirements. Employees who maintain records in
this system are instructed not to release data until the intended
recipient agrees to implement appropriate management, operational and
technical safeguards sufficient to protect the confidentiality,
integrity and availability of the information and information systems
and to prevent unauthorized access.
This system will conform to all applicable Federal laws and
regulations and Federal, HHS, and CMS policies and standards as they
relate to information security and data privacy. These laws and
regulations include but are not limited to: The Privacy Act of 1974;
the Federal Information Security Management Act of 2002; the Computer
Fraud and Abuse Act of 1986; the Health Insurance Portability and
Accountability Act of 1996; the E-Government Act of 2002, the Clinger-
Cohen Act of 1996; the Medicare Modernization Act of 2003, and the
corresponding implementing regulations. OMB Circular A-130, Management
of Federal Resources, Appendix III, Security of Federal Automated
Information Resources also applies. Federal, HHS, and CMS policies and
standards include but are not limited to: All pertinent National
Institute of Standards and Technology publications; the HHS Information
Systems Program Handbook and the CMS Information Security Handbook.
V. Effects of the Proposed System of Records on Individual Rights
CMS proposes to establish this system in accordance with the
principles and requirements of the Privacy Act and will collect, use,
and disseminate information only as prescribed therein. Data in this
system will be subject to the authorized releases in accordance with
the routine uses identified in this system of records.
CMS will take precautionary measures (see item IV above) to
minimize the risks of unauthorized access to the records and the
potential harm to individual privacy or other personal or property
rights of patients whose data are maintained in this system. CMS will
collect only that information necessary to perform the system's
functions. In addition, CMS will make disclosure from the proposed
system only with consent of the subject individual, or his/her legal
representative, or in accordance with an applicable exception provision
of the Privacy Act. CMS, therefore, does not anticipate an unfavorable
effect on individual privacy as a result of information relating to
individuals.
Dated: August 30, 2005.
John R. Dyer,
Chief Operating Officer, Centers for Medicare & Medicaid Services.
System No. 09-70-0560
SYSTEM NAME:
``Cancer Prevention and Treatment Demonstration for Ethnic and
Racial Minorities (CPTD),'' HHS/CMS/ORDI.
SECURITY CLASSIFICATION:
Level Three Privacy Act Sensitive Data.
SYSTEM LOCATION:
CMS Data Center, 7500 Security Boulevard, North Building, First
Floor, Baltimore, Maryland 21244-1850 and at various co-locations of
CMS agents.
CATEGORIES OF INDIVIDUALS COVERED BY THE SYSTEM:
This system will collect and maintain individually identifiable
demographic and cancer health-related data collected on Medicare target
population beneficiaries who voluntarily enroll in the Cancer
Prevention and Treatment Demonstration (CPTD) for Ethnic and Racial
Minorities. The system will maintain information on two populations:
(1) Medicare beneficiaries belonging to a defined ethnic or racial
minority group who do not have a current diagnosis of cancer before
enrollment in the demonstration project; and (2) Medicare beneficiaries
belonging to a defined ethnic or racial minority who have been
diagnosed with cancer before enrollment in the demonstration project.
CATEGORIES OF RECORDS IN THE SYSTEM:
The collected information will contain name, address, telephone
number, health insurance claim (HIC) number, race/ethnicity, gender
type, and date of birth, as well as background information relating to
Medicare issues. It will also include cancer screening, diagnosis,
treatment, project enrollment and evaluation, survey and research
information needed to administer the demonstration project and develop
research reports on the demonstration findings.
AUTHORITY FOR MAINTENANCE OF THE SYSTEM:
The statutory authority for this system is given under the
provisions of Section 122 of the Medicare, Medicaid, and State
Children's Health Insurance Program (SCHIP) Benefits Improvement and
Protection Act of 2000 (BIPA) (Pub. L. 106-554).
PURPOSE(S) OF THE SYSTEM:
The purpose of this system is to collect and maintain demographic
and cancer health-related data on Medicare target population
beneficiaries who voluntarily enroll in the CPTD Project for Ethnic and
Racial Minorities. This system will enable CMS to enroll eligible
participants in the demonstration project; randomize participants into
intervention and control groups; reimburse demonstration site service
claims; and develop, maintain and analyze/evaluate research information
showing the potential impact of providing cancer screening, diagnosis
and treatment facilitation services to underserved Medicare
beneficiaries. Information retrieved from this system may be disclosed
to: (1) Support regulatory, reimbursement, and policy functions
performed within the agency or by a contractor, grantee, consultant or
other legal agent; (2) assist another Federal or state agency with
information to enable such agency to administer a Federal health
benefits program, or to enable such agency to fulfill a requirement of
Federal statute or regulation that implements a health benefits program
funded in whole or in part with Federal funds; (3) assist an individual
or organization engaged in the performance activities of the
demonstration or in a research project or in support of an evaluation
project related to the prevention of disease or disability, the
restoration or maintenance of health, or payment related projects; (4)
support constituent requests made to a congressional representative;
(5) support litigation involving the agency; and (6) combat fraud and
abuse in certain health benefits programs.
ROUTINE USES OF RECORDS MAINTAINED IN THE SYSTEM, INCLUDING CATEGORIES
OR USERS AND THE PURPOSES OF SUCH USES:
A. The Privacy Act allows us to disclose information without an
individual's consent if the information is to be used for a purpose
that is compatible with the purpose(s) for which the information was
collected. Any such compatible use of data is
[[Page 57606]]
known as a ``routine use.'' We are proposing to establish the following
routine use disclosures of information maintained in the system.
Information will be disclosed to:
1. To agency contractors, grantees, consultants or other legal
agents who have been engaged by the agency to assist in the performance
of a service related to this system of records and who need to have
access to the records in order to perform the activity.
2. To another Federal or state agency to:
a. Contribute to the accuracy of CMS's proper payment of Medicare
benefits,
b. Enable such agency to administer a Federal health benefits
program, or as necessary to enable such agency to fulfill a requirement
of a Federal statute or regulation that implements a health benefits
program funded in whole or in part with Federal funds, and/or
c. Assist Federal/state Medicaid programs within the state.
3. To an individual or organization engaged in or assisting in the
enrollment, screening, diagnosis, treatment, evaluation, or research
efforts relative to beneficiary participation in the CPTD for Ethnic
and Racial Minorities (including summary analyses demonstrating the
impact of the demonstration project), and other activities reasonably
necessary to fulfill the provisions of the demonstration project and
ensure appropriate use of Medicare trust funds and program funds, as
well as to an individual or organization for a research project or in
support of an evaluation project related to the prevention of disease
or disability, the restoration or maintenance of health, or payment
related projects.
4. To a Member of Congress or to a congressional staff member in
response to an inquiry of the congressional office made at the written
request of the constituent about whom the record is maintained.
5. To the Department of Justice (DOJ), court or adjudicatory body
when:
a. The agency or any component thereof, or
b. Any employee of the agency in his or her official capacity, or
c. Any employee of the agency in his or her individual capacity
where the DOJ has agreed to represent the employee, or
d. The United States Government is a party to litigation or has an
interest in such litigation, and, by careful review, CMS determines
that the records are both relevant and necessary to the litigation and
that the use of such records by the DOJ, court or adjudicatory body is
compatible with the purpose for which the agency collected the records.
6. To a CMS contractor (including, but not necessarily limited to,
fiscal intermediaries and carriers) that assists in the administration
of a CMS-administered health benefits program, or to a grantee of a
CMS-administered grant program, when disclosure is deemed reasonably
necessary by CMS to prevent, deter, discover, detect, investigate,
examine, prosecute, sue with respect to, defend against, correct,
remedy, or otherwise combat fraud or abuse in such program.
7. To another Federal agency or to an instrumentality of any
governmental jurisdiction within or under the control of the United
States (including any State or local governmental agency), that
administers, or that has the authority to investigate potential fraud
or abuse in, a health benefits program funded in whole or in part by
Federal funds, when disclosure is deemed reasonably necessary by CMS to
prevent, deter, discover, detect, investigate, examine, prosecute, sue
with respect to, defend against, correct, remedy, or otherwise combat
fraud or abuse in such programs.
B. Additional Provisions Affecting Routine Use Disclosures:
This system contains Protected Health Information as defines by HHS
regulation ``Standards for Privacy of Individually Identifiable Health
Information'' (45 CFR Parts 160 and 164, 65 Federal Register 82462 (12-
28-00), Subparts A and E). Disclosures of Protected Health Information
authorized by these routine uses may only be made if and as permitted
or required by the ``Standards for Privacy of Individually Identifiable
Health Information.''
In addition, our policy will be to prohibit release even of not
directly identifiable information, except pursuant to one of the
routine uses or if required by law, if we determine there is a
possibility that an individual can be identified through implicit
deduction based on small cell sizes (instances where the complaint
population is so small that individuals who are familiar with the
complainants could, because of the small size, use this information to
deduce the identity of the complainant).
POLICIES AND PRACTICES FOR STORING, RETRIEVING, ACCESSING, RETAINING,
AND DISPOSING OF RECORDS IN THE SYSTEM:
STORAGE:
All records are stored electronically. Some input may be generated
in hardcopy, such as eligibility, enrollment, initial cancer status and
followup assessment information before transcription to electronic
media. All claims-related records are encompassed by the document
preservation order and will be retained until notification is received
from the Department of Justice.
RETRIEVABILITY:
The collected data are retrieved by an individual identifier; e.g.,
beneficiary name or HIC number.
SAFEGUARDS:
CMS has safeguards in place for authorized users and monitors such
users to ensure against excessive or unauthorized use. Personnel having
access to the system have been trained in the Privacy Act and
information security requirements. Employees who maintain records in
this system are instructed not to release data until the intended
recipient agrees to implement appropriate management, operational and
technical safeguards sufficient to protect the confidentiality,
integrity and availability of the information and information systems
and to prevent unauthorized access.
This system will conform to all applicable Federal laws and
regulations and Federal, HHS, and CMS policies and standards as they
relate to information security and data privacy. These laws and
regulations include but are not limited to: The Privacy Act of 1974;
the Federal Information Security Management Act of 2002; the Computer
Fraud and Abuse Act of 1986; the Health Insurance Portability and
Accountability Act of 1996; the E-Government Act of 2002, the Clinger-
Cohen Act of 1996; the Medicare Modernization Act of 2003, and the
corresponding implementing regulations. OMB Circular A-130, Management
of Federal Resources, Appendix III, Security of Federal Automated
Information Resources also applies. Federal, HHS, and CMS policies and
standards include but are not limited to: All pertinent National
Institute of Standards and Technology publications; the HHS Information
Systems Program Handbook and the CMS Information Security Handbook.
RETENTION AND DISPOSAL:
CMS will retain information for a total period not to exceed 25
years. Data residing with the designated demonstration project site
agent shall be returned to CMS at the end of the demonstration period,
with all data then being the responsibility of CMS for adequate storage
and security.
SYSTEM MANAGER AND ADDRESS:
Director, Office of Research Development and Information, CMS, Room
C3-20-11, 7500 Security Boulevard, Baltimore, Maryland 21244-1850.
[[Page 57607]]
NOTIFICATION PROCEDURE:
For the purpose of access, the subject individual should write to
the system manager who will require the system name, address, age,
gender type, and, for verification purposes, the subject individual's
name (woman's maiden name, if applicable).
RECORD ACCESS PROCEDURE:
For purpose of access, use the same procedures outlined in
Notification Procedures above. Requestors should also reasonably
specify the record contents being sought. (These procedures are in
accordance with Department regulation 45 CFR 5b.5(a)(2)).
CONTESTING RECORD PROCEDURES:
The subject individual should contact the system manager named
above, and reasonably identify the record and specify the information
to be contested. State the corrective action sought and the reasons for
the correction with supporting justification. (These procedures are in
accordance with Department regulation 45 CFR 5b.7).
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT:
None.
[FR Doc. 05-19676 Filed 9-30-05; 8:45 am]
BILLING CODE 4120-03-P